XML 136 R123.htm IDEA: XBRL DOCUMENT v3.24.0.1
Parent Company Only Condensed Financial Information - Condensed Statements of Cash Flows (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Cash flows from operating activities:      
Net income $ 103,533 $ 59,182 $ 43,164
Changes in operating assets and liabilities:      
Net cash provided by (used in) operating activities 125,176 96,915 113,109
Cash flows from investing activities:      
Cash acquired in excess of cash paid in connection with Pioneer Merger 0 444,542 0
Net cash used in investing activities (327,279) (538,120) (293,924)
Cash flows from financing activities:      
Proceeds from subordinated debt 0 24,466 0
Proceeds from issuance of common stock, net of issuance costs (167) (579) (456)
Net cash provided by financing activities 337,939 116,269 647,299
Net increase (decrease) in cash and cash equivalents 135,836 (324,936) 466,484
Cash and cash equivalents, beginning of period 343,526 668,462 201,978
Cash and cash equivalents, end of period 479,362 343,526 668,462
Parent      
Cash flows from investing activities:      
Cash acquired in excess of cash paid in connection with Pioneer Merger (150) (4,140) 0
Parent Company      
Cash flows from operating activities:      
Net income 103,533 59,182 43,164
Adjustments to reconcile income to net cash provided by (used in) operating activities:      
Amortization and accretion 533 1,529 1,095
(Equity) deficit in undistributed income of subsidiaries (83,837) (58,047) (49,729)
Changes in operating assets and liabilities:      
Other assets (419) (1,442) (4,250)
Other liabilities 2,911 293 3,479
Net cash provided by (used in) operating activities 22,721 1,515 (6,241)
Cash flows from investing activities:      
Payments for investments in and advances to subsidiaries 0 125 500
Contributions to subsidiaries (210) 0 0
Net cash used in investing activities (360) (4,015) 500
Cash flows from financing activities:      
Repayments of convertible notes payable (5,456) (15,217) 0
Proceeds from subordinated debt 0 24,466 0
Proceeds from issuance of common stock, net of issuance costs (167) (578) (66)
Net cash provided by financing activities (5,623) 8,671 (66)
Net increase (decrease) in cash and cash equivalents 16,738 6,171 (5,807)
Cash and cash equivalents, beginning of period 17,312 11,141 16,948
Cash and cash equivalents, end of period $ 34,050 $ 17,312 $ 11,141